Bevacizumab gamma (neovascular age-related macular degeneration); Benefit assessment according to §35a SGB V
Fields of Study & Subjects
Retinal Diseases and Treatments
Ocular Diseases and Behçet’s Syndrome
Retinal and Macular Surgery
Publication details
- Journal / source
- Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
- Publication date
- 11 February 2026
- Language
- EN